Related Experiment Video
Updated: May 20, 2025

Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
Published on: August 31, 2022
Burden of cancer attributable to excess red and processed meat consumption in Japan in 2015
Sarah Krull Abe1, Ribeka Takachi2, Junko Ishihara3
1Division of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Abstract:
The International Agency for Research on Cancer has evaluated red meat as probably carcinogenic and processed meat as carcinogenic to humans. The World Cancer Research Fund and American Institute for Cancer Research concluded there is convincing evidence that consumption of processed meat increases the risk of colorectal cancer. We estimated the number and fraction of cancer incidence and mortality in 2015 that could be attributed to excess red and processed meat consumption in 2005 among the Japanese population. Data on the consumption of red and ptocessed meat, in g/day, by sex and age group, is available for 2005 from the Japanese National Health and Nutrition Survey. For the present study, the optimal consumption of red meat in Japan was considered as less than 500 g/week, or 71.4 g/day, and 0 g/day for processed meat. Population attributable fractions (PAFs) were calculated for each sex and age group according to a standard formula, and aggregated to obtain the PAF among total cancer incidence and mortality. We found that 0.01% and 0.4% of cancer incidence was attributable to red and processed meat consumption, respectively, while 0.0002% and 0.3% of cancer mortality was attributable to red meat and to processed meat consumption. Based on the current evidence, monitoring red and processed meat consumption may not contribute to reducing cancer incidence and mortality in Japan.
Related Concept Videos
Cancer Prevention
Some...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mutagenicity and Carcinogenicity
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Targeted Cancer Therapies
There are several types of targeted therapies against...

